Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil



- TRADE NAME: Stribild (Gilead)
- INDICATIONS: HIV-1 infection
- CLASS: Antiretroviral, CYP3A inhibitor (cobicistat), Integrase strand transfer inhibitor (elvitegravir), Nucleoside analog reverse transcriptase inhibitor (emtricitabine and tenofovir disoproxil)
- HALF-LIFE: 3.5 hours (cobicistat); 13 hours (elvitegravir); 10 hours (emtricitabine); 12–18 hours (tenofovir disoproxil)
FDA APPROVAL DATE: 08/27/2012
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:Acyclovir, Adefovir, Amiodarone, Amitriptyline, Amlodipine, Antacids, Antirarrhythmics, Antiretrovirals, Atorvastatin, Benzodiazepines, Bepridil, Beta blockers, Bosentan, Buprenorphine, Bupropion, Buspirone, Calcium channel blockers, Carbamazepine, Cidofovir, Clarithromycin, Clonazepam, Clorazepate, Colchicine, Cyclosporine, Desipramine, Dexamethasone, Diazepam, Digoxin, Diltiazem, Disopyramide, Drugs affecting renal function, Elbasvir & Grazoprevir, Emtricitabine, Estazolam, Ethosuximide, Felodipine, Flecainide, Flurazepam, Fluticasone Propionate, Ganciclovir, Hormonal contraceptives, Imipramine, Immunosuppressants, Itraconazole, Ketoconazole, Lamivudine, Ledipasvir & Sofosbuvir, Lidocaine, Metoprolol, Mexiletine, Midazolam, Naloxone, Neuroleptics, Nicardipine, Nifedipine, Non-nucleoside reverse transcriptase inhibitors, Nortriptyline, Oxcarbazepine, Paroxetine Hydrochloride, Perphenazine, Phenobarbital, Phenytoin, Propafenone, Protease inhibitors, Quinidine, Rifabutin, Rifapentine, Risperidone, Ritonavir, Salmeterol, Sedatives / hypnotics, Sildenafil, Simeprevir, Sirolimus, SSRIs, Tacrolimus, Tadalafil, Telithromycin, Tenofovir Disoproxil, Thioridazine, Timolol, Trazodone, Tricyclic antidepressants, Valacyclovir, Valganciclovir, Vardenafil, Verapamil, Voriconazole, Warfarin, Zolpidem
PREGNANCY CATEGORY: B
See also separate profiles for emtricitabine and tenofovir disoproxil.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric